vTv Therapeutics (VTVT) Capital Expenditures (2014 - 2025)
vTv Therapeutics (VTVT) reported Capital Expenditures of -$24000.0 for Q4 2025, up 22.58% on a YoY basis from -$19578.9 in Q4 2024, and up 29.41% sequentially from -$34000.0 in Q3 2025.
vTv Therapeutics (VTVT) Capital Expenditures (2014 - 2025) Analysis & Trends
vTv Therapeutics (VTVT) has 7 years of Capital Expenditures data on file, last reported at -$24000.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures rose 22.58% year-over-year to -$24000.0; the trailing twelve-month figure through Mar 2026 stood at -$92000.0 (up 25.81% YoY), and the FY2025 full-year result was -$125000.0, down 5.04% from the prior year.
- Capital Expenditures climbed to -$24000.0 in Q4 2025, from -$34000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of -$24000.0 in Q4 2025 to a low of -$105000.0 in Q4 2023.
- A 3-year average of -$38777.8 and a median of -$31000.0 in 2024 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures soared 70.48% in 2024 and dropped 17.86% in 2025, its largest moves.
- Tracing VTVT's Capital Expenditures over 3 years: stood at -$105000.0 in 2023, then jumped by 70.48% to -$31000.0 in 2024, then advanced by 22.58% to -$24000.0 in 2025.
- Business Quant data shows VTVT's Capital Expenditures at -$24000.0 in Q4 2025, -$34000.0 in Q3 2025, and -$34000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 786,000.00 |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -24,000.00 |
| Dec 31, 2025 | -24,000.00 |
| Sep 30, 2025 | -34,000.00 |
| Sep 30, 2025 | -34,000.00 |
| Jun 30, 2025 | -34,000.00 |
| Jun 30, 2025 | -34,000.00 |
| Mar 31, 2025 | -33,000.00 |
| Mar 31, 2025 | -33,000.00 |
| Dec 31, 2024 | -31,000.00 |
| Dec 31, 2024 | -31,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Dec 31, 2023 | -105,000.00 |
| Dec 31, 2023 | -105,000.00 |
| Dec 31, 2017 | 18,000.00 |
| Dec 31, 2017 | 18,000.00 |